Sequential processing of human proIL-1β by caspase-1 and subsequent folding determined by a combined in vitro and in silico approach

P. W. Swaan, D. L. Knoell, F. Helsper, M. D. Wewers

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose. Interleukin-1β is a multifunctional cytokine produced by activated monocytes and macrophages that requires caspase-1 (IL-1 converting enzyme/ICE) to process the 31kDa inactive precursor protein to the biologically active 17kDa peptide. This activation event involves ICE cleavage at Asp27 (site 1) and Asp116 (site 2). To address the sequential processing at ICE cut sites we combined in vitro analysis and molecular modeling to investigate the sequence of molecular events. Methods. Pulse chase labeling followed by immunoprecipitation of IL-1β in activated human monocyte lysates demonstrated sequential cutting by ICE at site 1 before site 2 in vitro. To corroborate these findings, we constructed a homology model of proIL-1β after the crystal structure of another ICE substrate, human α1-antitrypsin (23% sequence identity). Results. Comparative modeling revealed that site 1 on proIL-1β is accessible to ICE but site 2 is not. Molecular dynamics simulations following ICE cleavage at site 1 and removal of the 3kDa aminoterminal fragment, rendered site 2 accessible to ICE. Conclusions. The close agreement between the in vitro and modeled behavior of IL-1β support our contention that IL-1β may be structurally related to α1-antitrypsin and also predicts that proIL-1β requires sequential processing for activation. These findings may facilitate the development of novel pharmacological agents that control posttranslational proIL-1β modification, thereby preventing excessive production of this potent inflammatory cytokine.

Original languageEnglish (US)
Pages (from-to)1083-1090
Number of pages8
JournalPharmaceutical Research
Volume18
Issue number8
DOIs
StatePublished - Oct 8 2001

Fingerprint

Caspase 1
Interleukin-1
Computer Simulation
Processing
Monocytes
Chemical activation
Cytokines
Molecular modeling
Protein Precursors
Macrophages
Molecular Dynamics Simulation
Immunoprecipitation
Labeling
Molecular dynamics
Crystal structure
In Vitro Techniques
Pharmacology
Peptides
Computer simulation
Substrates

Keywords

  • Comparative modeling
  • Cytokines
  • Inflammation
  • Molecular dynamics
  • Protein folding

ASJC Scopus subject areas

  • Biotechnology
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry
  • Pharmacology (medical)

Cite this

Sequential processing of human proIL-1β by caspase-1 and subsequent folding determined by a combined in vitro and in silico approach. / Swaan, P. W.; Knoell, D. L.; Helsper, F.; Wewers, M. D.

In: Pharmaceutical Research, Vol. 18, No. 8, 08.10.2001, p. 1083-1090.

Research output: Contribution to journalArticle

@article{0e6d6059fc5f4de69f1f6df8121e7df6,
title = "Sequential processing of human proIL-1β by caspase-1 and subsequent folding determined by a combined in vitro and in silico approach",
abstract = "Purpose. Interleukin-1β is a multifunctional cytokine produced by activated monocytes and macrophages that requires caspase-1 (IL-1 converting enzyme/ICE) to process the 31kDa inactive precursor protein to the biologically active 17kDa peptide. This activation event involves ICE cleavage at Asp27 (site 1) and Asp116 (site 2). To address the sequential processing at ICE cut sites we combined in vitro analysis and molecular modeling to investigate the sequence of molecular events. Methods. Pulse chase labeling followed by immunoprecipitation of IL-1β in activated human monocyte lysates demonstrated sequential cutting by ICE at site 1 before site 2 in vitro. To corroborate these findings, we constructed a homology model of proIL-1β after the crystal structure of another ICE substrate, human α1-antitrypsin (23{\%} sequence identity). Results. Comparative modeling revealed that site 1 on proIL-1β is accessible to ICE but site 2 is not. Molecular dynamics simulations following ICE cleavage at site 1 and removal of the 3kDa aminoterminal fragment, rendered site 2 accessible to ICE. Conclusions. The close agreement between the in vitro and modeled behavior of IL-1β support our contention that IL-1β may be structurally related to α1-antitrypsin and also predicts that proIL-1β requires sequential processing for activation. These findings may facilitate the development of novel pharmacological agents that control posttranslational proIL-1β modification, thereby preventing excessive production of this potent inflammatory cytokine.",
keywords = "Comparative modeling, Cytokines, Inflammation, Molecular dynamics, Protein folding",
author = "Swaan, {P. W.} and Knoell, {D. L.} and F. Helsper and Wewers, {M. D.}",
year = "2001",
month = "10",
day = "8",
doi = "10.1023/A:1010958406364",
language = "English (US)",
volume = "18",
pages = "1083--1090",
journal = "Pharmaceutical Research",
issn = "0724-8741",
publisher = "Springer New York",
number = "8",

}

TY - JOUR

T1 - Sequential processing of human proIL-1β by caspase-1 and subsequent folding determined by a combined in vitro and in silico approach

AU - Swaan, P. W.

AU - Knoell, D. L.

AU - Helsper, F.

AU - Wewers, M. D.

PY - 2001/10/8

Y1 - 2001/10/8

N2 - Purpose. Interleukin-1β is a multifunctional cytokine produced by activated monocytes and macrophages that requires caspase-1 (IL-1 converting enzyme/ICE) to process the 31kDa inactive precursor protein to the biologically active 17kDa peptide. This activation event involves ICE cleavage at Asp27 (site 1) and Asp116 (site 2). To address the sequential processing at ICE cut sites we combined in vitro analysis and molecular modeling to investigate the sequence of molecular events. Methods. Pulse chase labeling followed by immunoprecipitation of IL-1β in activated human monocyte lysates demonstrated sequential cutting by ICE at site 1 before site 2 in vitro. To corroborate these findings, we constructed a homology model of proIL-1β after the crystal structure of another ICE substrate, human α1-antitrypsin (23% sequence identity). Results. Comparative modeling revealed that site 1 on proIL-1β is accessible to ICE but site 2 is not. Molecular dynamics simulations following ICE cleavage at site 1 and removal of the 3kDa aminoterminal fragment, rendered site 2 accessible to ICE. Conclusions. The close agreement between the in vitro and modeled behavior of IL-1β support our contention that IL-1β may be structurally related to α1-antitrypsin and also predicts that proIL-1β requires sequential processing for activation. These findings may facilitate the development of novel pharmacological agents that control posttranslational proIL-1β modification, thereby preventing excessive production of this potent inflammatory cytokine.

AB - Purpose. Interleukin-1β is a multifunctional cytokine produced by activated monocytes and macrophages that requires caspase-1 (IL-1 converting enzyme/ICE) to process the 31kDa inactive precursor protein to the biologically active 17kDa peptide. This activation event involves ICE cleavage at Asp27 (site 1) and Asp116 (site 2). To address the sequential processing at ICE cut sites we combined in vitro analysis and molecular modeling to investigate the sequence of molecular events. Methods. Pulse chase labeling followed by immunoprecipitation of IL-1β in activated human monocyte lysates demonstrated sequential cutting by ICE at site 1 before site 2 in vitro. To corroborate these findings, we constructed a homology model of proIL-1β after the crystal structure of another ICE substrate, human α1-antitrypsin (23% sequence identity). Results. Comparative modeling revealed that site 1 on proIL-1β is accessible to ICE but site 2 is not. Molecular dynamics simulations following ICE cleavage at site 1 and removal of the 3kDa aminoterminal fragment, rendered site 2 accessible to ICE. Conclusions. The close agreement between the in vitro and modeled behavior of IL-1β support our contention that IL-1β may be structurally related to α1-antitrypsin and also predicts that proIL-1β requires sequential processing for activation. These findings may facilitate the development of novel pharmacological agents that control posttranslational proIL-1β modification, thereby preventing excessive production of this potent inflammatory cytokine.

KW - Comparative modeling

KW - Cytokines

KW - Inflammation

KW - Molecular dynamics

KW - Protein folding

UR - http://www.scopus.com/inward/record.url?scp=0034816911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034816911&partnerID=8YFLogxK

U2 - 10.1023/A:1010958406364

DO - 10.1023/A:1010958406364

M3 - Article

C2 - 11587477

AN - SCOPUS:0034816911

VL - 18

SP - 1083

EP - 1090

JO - Pharmaceutical Research

JF - Pharmaceutical Research

SN - 0724-8741

IS - 8

ER -